Griffin, Brendan T.

Gut reactions: Breaking down xenobiotic–microbiome interactions

Clarke, G., Sandhu, K. V., Griffin, B. T., Dinan, T. G., Cryan, J. F., & Hyland, N. P. (2019) · Pharmacological Reviews

Pharmacogenetics and Drug MetabolismGut microbiota and health

Cited by 319

Comparison of in vitro tests at various levels of complexity for the prediction of in vivo performance of lipid-based formulations: case studies with fenofibrate

Griffin, B. T., Kuentz, M., Vertzoni, M., Kostewicz, E. S., Fei, Y., Faisal, W., Stillhart, C., O’Driscoll, C. M., Reppas, C., & Dressman, J. B. (2014) · European Journal of Pharmaceutics and Biopharmaceutics

Drug Solubulity and Delivery SystemsAdvanced Drug Delivery Systems

Cited by 126

Exploring impact of supersaturated lipid-based drug delivery systems of celecoxib on in vitro permeation across PermeapadⓇ membrane and in vivo absorption

Ilie, A.-R., Griffin, B. T., Brandl, M., Bauer-Brandl, A., Jacobsen, A.-C., Vertzoni, M., Kuentz, M., Kolakovic, R., & Holm, R. (2020) · European Journal of Pharmaceutical Sciences

Drug Solubulity and Delivery SystemsAdvanced Drug Delivery Systems

Cited by 33

Novel Biphasic Lipolysis Method To Predict in Vivo Performance of Lipid-Based Formulations

O’Dwyer, P. J., Box, K. J., Koehl, N. J., Bennett-Lenane, H., Reppas, C., Holm, R., Kuentz, M., & Griffin, B. T. (2020) · Molecular Pharmaceutics

Drug Solubulity and Delivery SystemsAdvanced Drug Delivery Systems

Cited by 28